Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Features

IAVI at the World Vaccine Congress Europe

October 23, 2024

IAVI leaders will chair sessions and share the latest on our emerging infectious diseases program, vaccine innovation, and more at Europe’s largest vaccine conference.

Read more

Features

IAVI reflects on the changing HIV prevention landscape at HIVR4P 2024

October 18, 2024

Cross-disciplinary conversations highlighted recent progress in HIV vaccine and antibody research, as well as the importance of choice and community collaboration when developing HIV prevention strategies.

Read more

Features

Join IAVI at the 7th Global Forum on TB Vaccines

October 2, 2024

IAVI leaders to represent the full breadth of TB vaccine research, development, implementation, advocacy, and policy at the 7th Global Forum in Rio.

Read more

Features

IAVI at HIVR4P 2024, the 5th HIV Research for Prevention Conference

October 1, 2024

From HIV vaccine development to socio-behavioral research and community engagement in clinical trials, IAVI leaders are presenting on a range of pressing topics in HIV prevention research.

Read more

Features

First-ever Phase 2 Lassa vaccine clinical trial now fully active across West Africa

August 26, 2024

Researchers at three sites are vaccinating participants for Lassa fever, an emerging infectious disease with outbreaks in the region.

Read more

Features

Looking ahead to one of our busiest weeks of the year: IAVI at the International AIDS Conference

July 15, 2024

IAVI leaders will present on why we still need an HIV vaccine and how to engage communities in clinical trials and will launch an Action Plan for accelerating progress on broadly neutralizing antibodies for HIV prevention.

Read more

Features

IAVI signs lease on new Vaccine Design and Development Lab in Jersey City, NJ

July 10, 2024

New life sciences building to welcome IAVI’s emerging infectious disease vaccine research team.

Read more

Features

Unitaid, IAVI, Medicines Patent Pool, and Wellcome publish novel approaches to enable equitable access to monoclonal antibodies in low- and middle-income countries

July 5, 2024

With creativity and commitment, changing the status quo to enable access to promising new technologies is possible.

Read more